Immunotherapies targeting CD38 in Multiple Myeloma

Autor Atanackovic, Djordje, Steinbach, Mary, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim
Vydáno v Oncoimmunology (2016)

Novel anti-myeloma immunotherapies targeting the SLAM family of receptors

Autor Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Luetkens, Tim, Atanackovic, Djordje
Vydáno v Oncoimmunology (2017)

Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies

Autor Kobold, Sebastian, Luetkens, Tim, Cao, Yanran, Bokemeyer, Carsten, Atanackovic, Djordje
Vydáno 2010

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation

Autor Templin, Julia, Atanackovic, Djordje, Hasche, Daniel, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim
Vydáno v Oncotarget (2017)

Role of immunotherapy in Ewing sarcoma

Autor Morales, Erin, Olson, Michael, Iglesias, Fiorella, Dahiya, Saurabh, Luetkens, Tim, Atanackovic, Djordje
Vydáno v J Immunother Cancer (2020)

Elotuzumab as a novel anti-myeloma immunotherapy

Autor Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Steinbach, Mary, Weidner, Janet, Luetkens, Tim, Atanackovic, Djordje
Vydáno v Hum Vaccin Immunother (2017)

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

Autor Yousef, Sara, Heise, Johanna, Lajmi, Nesrine, Bartels, Katrin, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Vydáno v J Transl Med (2015)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

Autor Hendrickson, Peter G., Olson, Michael, Luetkens, Tim, Weston, Siani, Han, Tiffany, Atanackovic, Djordje, Fine, Gabriel C.
Vydáno v Oncoimmunology (2019)

5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity

Autor Stübig, Thomas, Badbaran, Anita, Luetkens, Tim, Hildebrandt, York, Atanackovic, Djordje, Binder, Thomas M. C., Fehse, Boris, Kröger, Nicolaus
Vydáno 2014

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

Autor Yousef, Sara, Kovacsovics-Bankowski, Magdalena, Salama, Mohamed E, Bhardwaj, Neelam, Steinbach, Mary, Langemo, Amanda, Kovacsovics, Tibor, Marvin, James, Binder, Mascha, Panse, Jens, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Vydáno v Hum Vaccin Immunother (2015)

Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients

Autor Kobold, Sebastian, Luetkens, Tim, Bartels, Britta Marlen, Cao, Yanran, Hildebrandt, York, Sezer, Orhan, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Lajmi, Nesrine, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje
Vydáno 2012

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

Autor Atanackovic, Djordje, Hildebrandt, York, Jadczak, Adam, Cao, Yanran, Luetkens, Tim, Meyer, Sabrina, Kobold, Sebastian, Bartels, Katrin, Pabst, Caroline, Lajmi, Nesrine, Gordic, Maja, Stahl, Tanja, Zander, Axel R., Bokemeyer, Carsten, Kröger, Nicolaus
Vydáno 2010

Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

Autor Kobold, Sebastian, Tams, Sinje, Luetkens, Tim, Cao, Yanran, Sezer, Orhan, Bartels, Britta Marlen, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Hildebrandt, York, Lajmi, Nesrine, Marx, Andreas, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje
Vydáno 2011

Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant

Autor Atanackovic, Djordje, Luetkens, Tim, Avila, Stephanie V., Hardy, Nancy M., Lutfi, Forat, Sanchez-Petitto, Gabriela, Vander Mause, Erica, Glynn, Nicole, Mannuel, Heather D., Alkhaldi, Hanan, Hankey, Kim, Baddley, John, Dahiya, Saurabh, Rapoport, Aaron P.
Vydáno v Vaccines (Basel) (2021)

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

Autor Radhakrishnan, Sabarinath V., Luetkens, Tim, Scherer, Sandra D., Davis, Patricia, Vander Mause, Erica R., Olson, Michael L., Yousef, Sara, Panse, Jens, Abdiche, Yasmina, Li, K. David, Miles, Rodney R., Matsui, William, Welm, Alana L., Atanackovic, Djordje
Vydáno v Nat Commun (2020)

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

Autor Atanackovic, Djordje, Reinhard, Henrike, Meyer, Sabrina, Spöck, Stefanie, Grob, Tobias, Luetkens, Tim, Yousef, Sara, Cao, Yanran, Hildebrandt, York, Templin, Julia, Bartels, Katrin, Lajmi, Nesrine, Stoiber, Heribert, Kröger, Nicolaus, Atz, Judith, Seimetz, Diane, Izbicki, Jakob R, Bokemeyer, Carsten
Vydáno 2013

Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19

Autor Luetkens, Tim, Metcalf, Ryan, Planelles, Vicente, Zheng, Yue, Larragoite, Erin T., Spivak, Emily S., Spivak, Adam M., Steinbach, Mary, Blaylock, Robert C., Avila, Stephanie V., Hankey, Kim G., Martins, Thomas B., Slev, Patricia R., Mannuel, Heather D., Sajadi, Mohammad, Rapoport, Aaron P., Atanackovic, Djordje
Vydáno v Blood Adv (2020)